Clinical trial

Juvista (Avotermin) in Scars Following Varicose Vein Removal

NCT00430326 · Renovo, Industry · Completed

Key facts

NCT number NCT00430326
Title Juvista (Avotermin) in Scars Following Varicose Vein Removal
Official title A Dose Response Trial to Investigate the Efficacy of Juvista (Avotermin) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins Following Bilateral Varicose Vein Removal.
Lead sponsor Renovo, Industry
Collaborators ICON Clinical Research Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Varicose Veins, Cicatrix
Intervention type Drug
Interventions Avotermin
Enrollment 156
Start date Nov 1, 2006
Primary completion Jan 1, 2009
Completion Apr 1, 2009
First posted Feb 1, 2007
Last update posted Mar 9, 2010
Countries Belgium, Latvia, Lithuania, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies